Peter J. Arduini - 02 Sep 2021 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role: President & CEO, Director
Signature: /s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol: IART
Transactions as of: 02 Sep 2021
Net transactions value: -$6,514,220
Form type: 4
Filing time: 07 Sep 2021, 16:12:49 UTC
Previous filing: 01 Jul 2021
Next filing: 01 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IART	Common Stock	Options Exercise	$1,499,790	+71,829	+33%	$20.88	288,542	02 Sep 2021	Direct	F1
transaction	IART	Common Stock	Sale	$5,456,662	-71,829	-25%	$75.97	216,713	02 Sep 2021	Direct	F1, F2
transaction	IART	Common Stock	Options Exercise	$973,112	+46,605	+22%	$20.88	263,318	03 Sep 2021	Direct	F1
transaction	IART	Common Stock	Sale	$3,530,459	-46,605	-18%	$75.75	216,713	03 Sep 2021	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IART	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-71,829	-61%	$0.000000	46,605	02 Sep 2021	Common Stock	71,829	$20.88	Direct	F1, F4, F5, F6
transaction	IART	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-46,605	-100%	$0.000000^*	0	03 Sep 2021	Common Stock	46,605	$20.88	Direct	F1, F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2	The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.34 to $76.465 per share of common stock.
F3	The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.40 to $76.09 per share of common stock.
F4	One-third of the stock options vested on the first anniversary of the grant date of March 6, 2014 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the third anniversary of the grant date.
F5	These options were previously reported as covering 56,727 shares at an exercise price of $48.27 per share, but were adjusted pursuant to the anti-dilution provisions of the award in connection with the separation of SeaSpine Holdings Corporation on July 1, 2015.
F6	In accordance with terms of the stock option plan, the exercise price of the options and the number of shares subject to the options have been adjusted to reflect the two-for-one stock split of the Issuer's common stock that occurred on December 21, 2016.